Literature DB >> 8053912

Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate.

M Vas1, A Merli, G L Rossi.   

Abstract

The analogue of ATP, 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate (TNP-ATP), binds tightly to pig muscle 3-phosphoglycerate kinase. A dissociation constant Kd of 0.0095 +/- 0.0015 mM was determined by fluorimetric titration on the basis of 1:1 stoichiometry. TNP-ATP is a strong competitive inhibitor towards MgATP and MgADP with a Ki of 0.008 +/- 0.001 mM for both substrates. It is also a mixed-type inhibitor towards 3-phosphoglycerate with similar inhibition constants. Binding of TNP-ATP to 3-phosphoglycerate kinase is accompanied by a tenfold intensity increase and a blue shift of about 20 nm in its fluorescence emission spectrum and a shift of the pK of its trinitrophenyl group towards a more acidic pH. These findings suggest that the negatively charged trinitrophenyl group of TNP-ATP significantly contributes to the binding of the analogue. By stepwise replacement of the fluorescent TNP-ATP, the dissociation constants (Kd) for ADP and MgADP binding were determined and found to be 0.78 +/- 0.08 and 0.048 +/- 0.006 mM respectively, which are consistent with the values previously determined by equilibrium dialysis [Molnár and Vas (1993) Biochem J. 293, 595-599]. In similar competitive-titration experiments, ATP and MgATP did not completely substitute for TNP-ATP. For the fraction of the analogue that could be substituted, the dissociation constants for MgATP and ATP were estimated to be 0.27 +/- 0.09 and 0.33 +/- 0.15 mM respectively, close to the values determined by equilibrium dialysis. Using the same method, a significant weakening of binding of both (Mg)ADP and (Mg)ATP could be detected in the presence of 3-phosphoglycerate: their respective Kd values became 0.34 +/- 0.04 and 0.51 +/- 0.22 mM. The reciprocal effect, i.e. weakening of 3-phosphoglycerate binding in the presence of the nucleotide substrates, has been observed previously [Vas and Batke (1984) Eur. J. Biochem. 139, 115-123]. Similarly, a much weaker binding of (Mg)ATP could be observed in the presence of 1,3-bisphosphoglycerate (Kd = 2.30 +/- 0.68 mM). The possible reason for the mutual weakening of substrate binding is discussed in the light of the available structural data.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053912      PMCID: PMC1137069          DOI: 10.1042/bj3010885

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  The mechanism of ATP inhibition of wild type and mutant phosphofructo-1-kinase from Escherichia coli.

Authors:  R L Zheng; R G Kemp
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

2.  Adenylyl imidodiphosphate, an adenosine triphosphate analog containing a P--N--P linkage.

Authors:  R G Yount; D Babcock; W Ballantyne; D Ojala
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Inhibition of phosphoglycerate kinase by products and product homologues.

Authors:  M Larsson-Raźnikiewicz; L Arvidsson
Journal:  Eur J Biochem       Date:  1971-10-26

4.  Kinetic studies on the reaction catalyzed by phosphoglycerate kinase. II. The kinetic relationships between 3-phosphoglycerate, MgATP2-and activating metal ion.

Authors:  M Larsson-Raźnikiewicz
Journal:  Biochim Biophys Acta       Date:  1967-01-11

5.  Crystal structure of the binary complex of pig muscle phosphoglycerate kinase and its substrate 3-phospho-D-glycerate.

Authors:  K Harlos; M Vas; C F Blake
Journal:  Proteins       Date:  1992-02

6.  31P NMR studies of enzyme-bound substrate complexes of yeast 3-phosphoglycerate kinase: III. Two ADP binding sites and their Mg(II) affinity; effects of vanadate and arsenate on enzymic complexes with ADP and 3-P-glycerate.

Authors:  B D Ray; J M Moore; B D Rao
Journal:  J Inorg Biochem       Date:  1990-09       Impact factor: 4.155

7.  Arrangement of substrates at the active site of yeast phosphoglycerate kinase. Effect of sulfate ion.

Authors:  J D Gregory; E H Serpersu
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

8.  The binding of the fluorescent ATP analogue 2'(3')-trinitrophenyladenosine-5'-triphosphate to rat liver fatty acid-binding protein.

Authors:  M Sheridan; D C Wilton
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

9.  The adenine nucleotide-binding site on yeast 3-phosphoglycerate kinase. Affinity labeling of Lys-131 by pyridoxal 5'-diphospho-5'-adenosine.

Authors:  J R LaDine; R L Cross
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

10.  MgATP and fructose 6-phosphate interactions with phosphofructokinase from Escherichia coli.

Authors:  J L Johnson; G D Reinhart
Journal:  Biochemistry       Date:  1992-11-24       Impact factor: 3.162

View more
  5 in total

1.  Conformational changes produced by ATP binding to the plasma membrane calcium pump.

Authors:  Irene C Mangialavori; Mariela S Ferreira-Gomes; Nicolás A Saffioti; Rodolfo M González-Lebrero; Rolando C Rossi; Juan Pablo F C Rossi
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

2.  A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.

Authors:  Michael T Guarnieri; Brian S J Blagg; Rui Zhao
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

3.  The effects of temperature on the kinetics and stability of mesophilic and thermophilic 3-phosphoglycerate kinases.

Authors:  T M Thomas; R K Scopes
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

4.  Molecular mechanism of glycolytic flux control intrinsic to human phosphoglycerate kinase.

Authors:  Hiromasa Yagi; Takuma Kasai; Elisa Rioual; Teppei Ikeya; Takanori Kigawa
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

5.  Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells.

Authors:  Monika Raab; Fiona Pachl; Andrea Krämer; Elisabeth Kurunci-Csacsko; Christina Dötsch; Rainald Knecht; Sven Becker; Bernhard Kuster; Klaus Strebhardt
Journal:  Cell Res       Date:  2014-07-01       Impact factor: 25.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.